Pioneer Surgical Technology, Inc. has expanded its foothold in Germany.
Pioneer Surgical Expands in Germany

On December 21, the company announced the creation of Pioneer Surgical Technology Deutschland GMBH. With offices located in Konstanz, Germany, the company is positioned, according to the announcement, to put Pioneer closer to its surgeon and hospital customers in Germany by establishing a commercial center that will be solely focused on this key market.
The team in Germany consists of five territory managers led by Joerg Maassen, Business Unit Manager – Germany. He says, “Our team is enthusiastic about expanding the presence of Pioneer Surgical Global Spine and becoming a valuable contributor to the overall Pioneer Surgical organization.”
Pioneer’s Executive Vice President of Global Distribution Spine, Jim St. John, said “Our strategy is for Pioneer Surgical Global Spine to be recognized as a market leader in providing innovative surgical solutions that benefit the patient, surgeon and hospitals around the world. Our goal is to nimbly address individual market needs through a combination of dedicated personnel and customized product offerings tailored to the unique requirements of individual markets as substantiated by careful business analysis.”
Pioneer was founded in Marquette, Michigan in, 1992 by Matthew Songer, M.D. The company has several facilities throughout the U.S. and in Houten, The Netherlands, and employs nearly 300 people worldwide.
Germany is the largest spine market in Europe and third largest in the world.

Discussion
This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?
Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.
We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.
Join the conversation
Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.